Details for New Drug Application (NDA): 216662
✉ Email this page to a colleague
NDA 216662 describes LINCOMYCIN HYDROCHLORIDE, which is a drug marketed by Arthur Grp, Gland Pharma Ltd, Micro Labs, Slate Run Pharma, Slayback, and Xgen Pharms, and is included in six NDAs. It is available from nine suppliers. Additional details are available on the LINCOMYCIN HYDROCHLORIDE profile page.
The generic ingredient in LINCOMYCIN HYDROCHLORIDE is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
The generic ingredient in LINCOMYCIN HYDROCHLORIDE is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
Summary for 216662
| Tradename: | LINCOMYCIN HYDROCHLORIDE |
| Applicant: | Slate Run Pharma |
| Ingredient: | lincomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 216662
Suppliers and Packaging for NDA: 216662
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 216662 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-034 | 70436-034-82 | 10 VIAL in 1 CARTON (70436-034-82) / 2 mL in 1 VIAL |
| LINCOMYCIN HYDROCHLORIDE | lincomycin hydrochloride | INJECTABLE;INJECTION | 216662 | ANDA | Slate Run Pharmaceuticals, LLC | 70436-035 | 70436-035-80 | 1 VIAL in 1 CARTON (70436-035-80) / 10 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 300MG BASE/ML | ||||
| Approval Date: | Dec 21, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
